Managers

Legal battle continues over public beach access at Khosla's property

Republican tax plan preserves carried interest tax treatment

Ranger Health ropes in $10 mln Series A

San Antonio, Texas-based Ranger Health, an on-demand healthcare service and technology company, has raised $10 million in Series A funding. Ranger Health's backers included HOLT Ventures.

VC-backed Spero Therapeutics goes public

Cambridge, Massachusetts-based Spero Therapeutics, a biopharmaceutical company focused on developing treatments for bacterial infections, has debuted its IPO after pricing its 5.5 million shares at $14 per share. Spero began trading on the NASDAQ under the ticker symbol “SPRO.” BofA Merrill Lynch, Cowen and Company LLC and Stifel are the lead underwriters. Spero’s backers include GV, RA Capital Management, Rock Springs Capital, Atlas Venture, MRL Ventures Fund, Lundbeckfonden Ventures, The Kraft Group and Osage University Partners.

VC-backed Allena debuts IPO

Newton, Massachusetts-based Allena Pharmaceuticals, a developer of treatments for patients with rare and severe metabolic and kidney disorders, has raised about $75 million for its IPO after pricing its over 5.3 million share at $14 per share. The stock began trading November 2, 2017 on the NASDAQ under the ticker symbol "ALNA." Credit Suisse, Jefferies and Cowen are the lead underwriters. Allena's investors included Frazier Healthcare, Bessemer Venture Partners, HBM Partners, Fidelity and Partner Fund Management.

Aisling Capital raises $280 mln for fund

Aisling Capital, a late-stage life sciences investment firm, has closed its latest fund at $280 million. The fund will focus on "helping clinical stage ventures improve global health."

BCBSVP-backed Oncology Analytics taps Dean as CEO

Oncology Analytics, an oncology benefits management and analytics company serving health plans, providers and health plan members in the U.S. and Puerto Rico, has appointed Rick Dean as CEO. The appointment is effective immediately. Dr. Mark Fishman, the company's founder and former CEO, will become executive chairman. Previously, Dean worked at Optum, the healthcare services arm of UnitedHealth Group where he was a founding member of Optum Ventures, a digital health-focused fund. Oncology Analytics is backed by BlueCross BlueShield Venture Partners.

VC Video Interview: Entrepreneurship in Dubai

Further to go: women, technology and VC in Canada

Vertical Venture Partners seeks $80 mln for enterprise tech

Menlo Park, California-based Vertical Venture Partners is seeking to raise $80 million for its second fund, according to a regulatory filing. The firm, which focuses on enterprise companies that target vertical markets, raised $51.3 million for its first fund. The firm was founded by Managing Partner David Schwab, who previously was with Sierra Ventures.